ETF comparison

XBI vs XLV

Both Healthcare.

State Street SPDR S&P Biotech ETF · State Street Health Care Select Sector SPDR ETF

Holdings overlap

Weighted by ISIN/CUSIP
6.5 %

9 positions appear in both funds. Buying equal dollars of XBI and XLV would leave roughly 6.5% of each dollar exposed to the same underlying securities.

XBI only 93.4% Shared 6.5% XLV only 93.2%
In XBI only
145 positions
Shared
9 positions
In XLV only
51 positions

Side by side

XBI

State Street SPDR S&P Biotech ETF

State Street · Healthcare

81 composite / 100
Expense ratio
0.35%
Net assets
$10.73B
TTM yield
0.37%
Top-10 conc.
20.4%
XLV

State Street Health Care Select Sector SPDR ETF

State Street · Healthcare

83 composite / 100
Expense ratio
0.080%
Net assets
$40.60B
TTM yield
1.60%
Top-10 conc.
59.1%

Sub-score comparison

65
Cost
92
85
Tax efficiency
82
100
Liquidity
100
85
Concentration
30
Tracking quality
XBI sub-score XLV

Tracking quality isn't part of the composite — see what we don't score for why.

Cost difference

XLV is 27 bps cheaper than XBI. On a $100,000 position that's about $270/yr more in fees for XBI.

Fee figure is the annual expense charged on $100,000. To see how the gap compounds over a multi-decade holding period, open the cost calculator pre-filled with XBI vs XLV.

Top shared holdings

9 shared in total
# Holding In XBI In XLV Overlap
1 Regeneron Pharmaceuticals Inc 1.14% 1.47% 1.14%
2 AbbVie Inc 1.09% 7.25% 1.09%
3 Gilead Sciences Inc 1.09% 3.26% 1.09%
4 Amgen Inc 1.06% 3.57% 1.06%
5 Vertex Pharmaceuticals Inc 1.03% 2.14% 1.03%
6 Biogen Inc 1.10% 0.51% 0.51%
7 Moderna Inc 1.03% 0.33% 0.33%
8 Incyte Corp 1.13% 0.30% 0.30%
9 State Street Global Advisors 0.00% 0.01% 0.00%

Only in XBI

145 total
  • Apellis Pharmaceuticals Inc 1.83%
  • Alkermes PLC 1.45%
  • Madrigal Pharmaceuticals Inc 1.38%
  • TG Therapeutics Inc 1.35%
  • Insmed Inc 1.34%
  • Scholar Rock Holding Corp 1.30%
  • Apogee Therapeutics Inc 1.28%
  • Protagonist Therapeutics Inc 1.24%
  • Summit Therapeutics Inc 1.24%
  • United Therapeutics Corp 1.24%

Only in XLV

51 total
  • Eli Lilly & Co 13.74%
  • Johnson & Johnson 11.10%
  • Merck & Co Inc 5.63%
  • UnitedHealth Group Inc 4.62%
  • Thermo Fisher Scientific Inc 3.48%
  • Abbott Laboratories 3.37%
  • Intuitive Surgical Inc 3.09%
  • Pfizer Inc 3.01%
  • Bristol-Myers Squibb Co 2.33%
  • Danaher Corp 2.25%

Open XBI or XLV at a brokerage

Both funds trade commission-free at major US brokerages.

Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodology and funding disclosure.

Holdings overlap is the sum of min(weight_a, weight_b) over positions matched on ISIN (CUSIP fallback). Methodology: see /methodology/.

Comparing two funds doesn't endorse swapping one for the other. Tax-lot history, account type, and personal goals matter — PlainIndex publishes data and methodology, not investment advice.